PTEN and Familial prostate cancer: In male mice with prostate epithelium-specific Pten-knockout mouse prostate cancer model, low dose of rapamycin (formulated as Rapatar) was effective in suppressing proliferation of prostate epithelial cells and prevention of prostate cancer.